Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

Journal of Clinical Investigation

Volumn 90, Issue 3, 1992, Pages 1138-1144

  Kume, Noriaki ^a   Cybulsky, Myron I ^a   Gimbrone Jr , Michael A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Inflammation; Intercellular adhesion molecule 1; Oxidized low density lipoprotein; Vascular cell adhesion molecule 1

Indexed keywords

CHEMOATTRACTANT; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; FLUORESCENCE ANALYSIS; FOAM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ILIAC ARTERY; LEUKOCYTE ADHERENCE; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN INDUCTION; RABBIT; RAT; RNA ANALYSIS; UMBILICAL VEIN;

ANIMAL; ARTERIOSCLEROSIS; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMAN; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MALE; PHOSPHOLIPIDS; RABBITS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0026781978     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115932     Document Type: Article

References (49)

1. Ross, R. 1986. The pathogenesis of atherosclerosis-An update. N. Engl. J. Med. 314:488-500.
2. Munro, J. M., and R. S. Cotran. 1988. The pathogenesis of atherosclerosis: Atherosclerosis and inflammation. Lab. Invest. 58:249-261.
3. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
4. Gerrity, R. G., H. K. Naito, M. Richardson, and C. J. Schwartz. 1979. Dietary induced atherogenesis in swine. Am. J. Pathol. 95:775-785.
5. Joris, T., J. J. Nunnari, F. J. Krolikowski, and G. Majno. 1983. Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am. J. Pathol. 113:341-358.
6. Faggiotto, A., R. Ross, and L. Harker. 1984. Studies of hypercholesterolemia in the nonhuman primates. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-340.
7. Ylä-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, T. Sarkioja, T. Yoshimura, E. J. Leonard, J. L. Witztum, and D. Steinberg. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich area of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88:5252-5256.
8. Nelken, N. A., S. R. Coughlin, D. Gordon, and J. N, Wilcox. 1991. Monocyte chemoattractant protein-1 in human atherosclerotic plaques. J. Clin. Invest. 88:1121-1127.
9. Cushing, S. D., J. A. Berliner, A. J. Valente, M. Navab, F. Parhami, R. Gerrity, C. J. Schwartz, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
10. Simmons, D., M. W. Makgoba, and B. Seed. 1988. ICAM. An adhesion ligand of LFA-1 is homologous to the neural cell adhesion molecule NCAM. Nature (Lond.). 331:624-627.
11. Staunton, D. E., S. D. Marlin, C. Stratowa, M. L. Dustin, and T. A. Springer. 1988. Primary structure of ICAM-1 demonstrates interaction between members of immunoglobulin and integrin supergene families. Cell. 52:925-933.
12. Bevilacqua, M. P., S. Stengelin, M. A. Gimbrone, Jr., and B. Seed. 1989. Endothelial leukocyte adhesion molecule 1: an inducible adhesion receptor to neutrophils related to complement regulatory proteins and lectins. Science (Wash. DC). 243:1160-1165.
13. Bevilacqua, M., E. Butcher, B. Furie, M. Gallatin, M. Gimbrone, J. Harlan, K. Kishimoto, L. Lasky, R. McEver, J. Paulson, et al. 1991. Selectins: a family of adhesion receptors. Cell. 67:233.
14. Osborn, L., C. Hession, R. Tizard, C. Vassalio, S. Luhowsky, G. Chi-Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1. A cytokine-induced endothelial protein that bind lymphocytes. Cell. 59:1203-1211.
15. Rice, G. E., J. M. Munro, and M. P. Bevilacqua. 1990. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/CD18-independent adhesion mechanisms. J. Exp. Med. 171:1369-1374.
16. Carlos, T., N. Kovach, B. Schwartz, M. Rosa, B. Newman, E. Wayner, C. Benjamin, L. Osborn, R. Lobb, and J. Harlan. 1991. Human monocyte bind to two cytokine-induced adhesion ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood. 77:2266-2271.
17. Cybulsky, M. I., and M. A. Gimbrone, Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Wash. DC). 251:788-791.
18. Li, H., M. I. Cybulsky, M. A. Gimbrone, Jr., and P. Libby. 1991. Early induction of an atherosclerosis-associated endothelial-leukocyte molecule (Athero-ELAM) by an atherogenic diet in rabbits. Arterioscler. Thromb. 11:1397a. (Abstr.)
19. Poston, R. N., D. O. Haskard, J. R. Coucher. N. P. Gall, and R. R. Johnson-Tiedy. 1992. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140:665-673.
20. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
21. Kita, T., Y. Nagano, M. Yokode, K., Ishii, N. Kume, A. Ooshima, H. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:5928-5931.
22. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidant in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc. Natl. Acad. Sci. USA. 84:7725-7729.
23. Palinski, W., M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1372-1380.
24. Quinn, M. T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA. 85:2805-2809.
25. Parthasarathy, S., M. T. Quinn, D. C. Schwenke, T. E. Carew, and D. Steinberg. 1989. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 9:398-404.
26. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. Henry. 1990. Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (Lond.). 344:160-162.
27. Yokoyama, M., K. Hirata, R. Miyake, H. Akita, Y. Ishikawa, H. Fukuzaki. 1990. Lysophosphatidylcholine: essential role in the inhibition of endothelial-dependent vasorelaxation by oxidized low density lipoprotein. Biochem. Biophys. Res. Commun. 16:301-308.
28. Portman, O. W., and M. Alexander. 1969. Lysophosphatidylcholine concentration and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid Res. 10:158-165.
29. Luscinskas, F. W., A. F. Brock, A. Arnaout, and M. A. Gimbrone, Jr. 1989. Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J. Immunol. 142:2257-2263.
30. Luscinskas, F. W., M. I. Cybulsky, J. M. Kiely, C. S. Peckins, V. M. Davis. and M. A. Gimbrone, Jr. 1991. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J. Immunol. 146:1617-1625.
31. Rice, G. E., and M. P. Bevilacqua. 1989. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (Wash. DC). 246:1303-1306.
32. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
33. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular Cloning, a Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
34. Cybulsky, M. I., J. W. U. Fries, A. J. Williams, P. Sultan, V. M. Davies, M. A. Gimbrone, Jr., and T. Collins. 1991. Alternative splicing of human VCAM-1 in activated vascular endothelium. Am. J. Pathol. 138:815-820.
35. Bergmann, S. R., T. B. Ferguson, Jr., and B. E. Sobel. 1981. Effects of amphiphiles on erythrocytes, coronary arteries and perfused hearts. Am. J. Physiol. H229-H237.
36. Quinn, M. T., N. Kondratenko, and S. Parthasarathy. 1991. Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. Biochim. Biophys. Acta. 1082:293-302.
37. Libby, P., and G. K., Hansson. 1991. Involvement of the immune system in human atherosclerosis: current knowledge and unanswered questions. Lab. Invest. 64:5-15.
38. Schwenke, D. C., and T. E. Carew. 1989. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis. 9:895-907.
39. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-1266.
40. Territo, M. C., J. A. Berliner, L. Almada, R. Ramirez, and A. M. Fogelman. 1989. β-VLDL pretreatment of endothelial monolayers increases monocyte but not neutrophil adhesion. Arteriosclerosis. 9:824-828.
41. Kume, N., H. Arai, C. Kawai, and T. Kita. 1991. Receptors for modified low-density lipoproteins in human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim. Biophys. Acta. 1091:63-67.
42. Clinton, S. K., R. Underwood, L. Hayes, M. L. Sherman, D. W. Kufe, and P. Libby. 1992. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140:301-316.
43. Nishijima, J., T. M. Wright, R. D. Hofman, F. Liao, D. E. Symer, and H. S. Shin. 1989. Lysophosphatidylcholine metabolism to 1,2-diacylglycerol in lymphoblasts: involvement of a phosphatidylcholine-hydrolyzing phospholipase C. Biochemistry. 28:2902-2909.
44. Nishizuka, Y. 1988. Molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (Lond.). 334:661-665.
45. Ritchie, A. J., D. R. Johnson, B. M. Ewenstein, and J. S. Pober. 1991. Tumor necrosis factor induction of endothelial cell surface antigen is independent of protein kinase C activation or inactivation: studies with phorbol myristate acetate and staurosporine. J. Immunol. 146:3056-3062.
46. Montgomery, K., F., L. Osborn, C. Hession, R. Tizard, D. Goff, C. Vassalo, P. I. Tarr, K. Bomsztyk, R. Lobb, J. M. Marian, and T. H. Pohlman. 1991. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA. 88:6523-6527.
47. Deisher, T. A., T. L. Haddix, K. F. Montgomery, T. H. Pohlman, and J. M. Harlan. 1991. Differential regulation of ELAM-1 and VCAM-1 expression in human umbilical vein endothelial cells by protein kinase C. Circulation. 84:11-404. (Abstr.)
48. Nakano, T., E. W. Raines, J. A. Abraham, M. Klagsbrun, and R. Ross. 1992. Lysophosphatidylcholine induces monocyte expression of heparin-binding EGF-like growth factor mRNA. J. Cell. Biochem. Suppl. 16A:18. (Abstr.)
49. 2 in the pathobiology of disease. Lab. Invest. 55:391-404.